When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RVNC - Revance Therapeutics shares 7% higher after large CEO buy
Revance Therapeutics Inc.
Shares of Revance Therapeutics (RVNC +7.2%) are trading up today following CEO Mark Foley's purchase of 40K shares. Foley acquired the shares yesterday at an average price of $12.90 for a total purchase price of $515,924. He now owns 110,913 shares individually and an additional 769,065 shares through a family trust. Revance stock was hurt last month after the FDA issued a Complete Response Letter for the company's BLA for DaxibotulinumtoxinA injection for moderate to severe glabellar (frown) lines.